LONDON (Reuters) - U.S. drugmaker Pfizer has raised its offer for AstraZeneca to 63 billion pounds ($106 billion), it said on Friday, adding that the British drugmaker was reviewing the proposal.
via elEconomista empresas http://ift.tt/1iJTXp0 http://ift.tt/eA8V8J
via elEconomista empresas http://ift.tt/1iJTXp0 http://ift.tt/eA8V8J
No hay comentarios:
Publicar un comentario